John Osei Sekyere
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
John Osei Sekyere has a total of 104 co-authors. Here are the top co-authors by number of shared publications:
Nontombi Marylucy Mbelle
Department of Medical Microbiology, School of Medicine University of Pretoria Pretoria South Africa
18 shared publications- Nontuthuko Excellent Maningi
Department of Medical Microbiology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa
16 shared publications - Sabiha Yusuf Essack
Antimicrobial Research Unit, College of Health Sciences, University of KwaZulu-Natal, Durban 4000, South Africa
16 shared publications - Nontombi Mbelle
University of Pretoria
13 shared publications - Daniel Gyamfi Amoako
Antimicrobial Research Unit, University of KwaZulu-Natal, Durban 4000, South Africa
10 shared publications Lesedi Modipane
Department of Medical Microbiology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa
8 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by AOSIS in Southern African Journal of Infectious Diseases
- Vol. 41 (1) , 10
A bibliometric analysis of the literature on Mycoplasma and Ureaplasma infections
Background: Mycoplasma and Ureaplasma species are understudied opportunistic pathogens that infect humans, animals and plants. These infections are often asymptomatic, which, together with fastidious growth requirements, makes them challenging to detect. Aim: The review aimed to provide a bibliometric analysis of available literature to reflect and assess trends, progress and knowledge gaps in this field. Setting: This article is a literature review. Method: A bibliometric analysis of 19 486 documents from 1992 to 2022 was conducted using the Web of Science database and in-depth analyses on RStudio. Results: China and the United States produced a high number of publications and citations. South Africa, the first most-cited African country, contributed 685 publications, ranking 24th globally with 2031 citations. Veterinary Microbiology was the highest performing journal with 448 papers and 10 036 citations. The most frequent keywords were ‘infection’ and ‘Ureaplasma urealyticum’. Conclusion: Research on Mycoplasma and Ureaplasma infections has progressed over time, but mainly in developed countries. The restricted publications and moderate citations in South Africa suggest research gaps in understanding the true burden and impacts of these infections. Contribution: This study provides a comprehensive bibliometric overview of Mycoplasma and Ureaplasma infections and reports the global and local progress in this field. The overall moderate, steady growth highlights the need for broader international collaboration and expanded research efforts in low-resource countries to address existing research gaps. This expansion is essential, particularly in clinical research, for strengthening both surveillance and treatment guidelines.
- 1 January 2026
- Published by AOSIS in Southern African Journal of Infectious Diseases
- Vol. 41 (1) , 10
Open AccessA bibliometric analysis of the literature on Mycoplasma and Ureaplasma infections
Background: Mycoplasma and Ureaplasma species are understudied opportunistic pathogens that infect humans, animals and plants. These infections are often asymptomatic, which, together with fastidious growth requirements, makes them challenging to detect. Aim: The review aimed to provide a bibliometric analysis of available literature to reflect and assess trends, progress and knowledge gaps in this field. Setting: This article is a literature review. Method: A bibliometric analysis of 19 486 documents from 1992 to 2022 was conducted using the Web of Science database and in-depth analyses on RStudio. Results: China and the United States produced a high number of publications and citations. South Africa, the first most-cited African country, contributed 685 publications, ranking 24th globally with 2031 citations. Veterinary Microbiology was the highest performing journal with 448 papers and 10 036 citations. The most frequent keywords were ‘infection’ and ‘Ureaplasma urealyticum’. Conclusion: Research on Mycoplasma and Ureaplasma infections has progressed over time, but mainly in developed countries. The restricted publications and moderate citations in South Africa suggest research gaps in understanding the true burden and impacts of these infections. Contribution: This study provides a comprehensive bibliometric overview of Mycoplasma and Ureaplasma infections and reports the global and local progress in this field. The overall moderate, steady growth highlights the need for broader international collaboration and expanded research efforts in low-resource countries to address existing research gaps. This expansion is essential, particularly in clinical research, for strengthening both surveillance and treatment guidelines.
- Top Cited PapersOpen Access
- 26 November 2025
- Published by Wiley in Microbiologyopen
- Vol. 14 (6) , e70104
Next‐Generation Sequencing in Infectious‐Disease Diagnostics: Economic, Regulatory, and Clinical Pathways to Adoption
Next‐generation sequencing (NGS) has emerged as a transformative tool for infectious disease diagnosis, offering broad pathogen detection, antimicrobial resistance profiling, and syndromic panel testing. However, widespread clinical adoption remains hindered by insurance reimbursement challenges, high costs, and regulatory barriers. Unlike polymerase chain reaction (PCR), which enjoys well‐established Current Procedural Terminology (CPT) codes and reimbursement pathways, many NGS‐based tests lack standardized billing mechanisms, discouraging laboratories from integrating NGS into routine diagnostics. This article explores the economic, clinical, and technological considerations of targeted amplicon sequencing (tNGS) versus PCR and whole‐genome sequencing (WGS), demonstrating how optimized multiplexing strategies, emerging NGS platforms, and regulatory advancements can enhance feasibility. It is argued that insurance policies must evolve to recognize NGS's superior clinical utility in detecting polymicrobial infections, emerging pathogens, and antimicrobial resistance determinants, ultimately improving patient outcomes and reducing healthcare costs. Current reagent‐only costs now average US $65 per microbial genome, US $600 per 30× human genome, and US $130–600 per metagenomic sample when multiplexed; these figures continue to fall with higher multiplexing. To accelerate equitable adoption, we recommend near‐term payer coverage pilots for clearly defined clinical indications, dedicated CPT pathways for infectious‐disease sequencing (including metagenomic assays), and pragmatic validation frameworks that acknowledge genotype–phenotype limits while leveraging multiplexing and centralized reference workflows.
- 26 November 2025
- Published by Wiley in Microbiologyopen
- Vol. 14 (6) , e70104
Top Cited PapersOpen AccessNext‐Generation Sequencing in Infectious‐Disease Diagnostics: Economic, Regulatory, and Clinical Pathways to Adoption
Next‐generation sequencing (NGS) has emerged as a transformative tool for infectious disease diagnosis, offering broad pathogen detection, antimicrobial resistance profiling, and syndromic panel testing. However, widespread clinical adoption remains hindered by insurance reimbursement challenges, high costs, and regulatory barriers. Unlike polymerase chain reaction (PCR), which enjoys well‐established Current Procedural Terminology (CPT) codes and reimbursement pathways, many NGS‐based tests lack standardized billing mechanisms, discouraging laboratories from integrating NGS into routine diagnostics. This article explores the economic, clinical, and technological considerations of targeted amplicon sequencing (tNGS) versus PCR and whole‐genome sequencing (WGS), demonstrating how optimized multiplexing strategies, emerging NGS platforms, and regulatory advancements can enhance feasibility. It is argued that insurance policies must evolve to recognize NGS's superior clinical utility in detecting polymicrobial infections, emerging pathogens, and antimicrobial resistance determinants, ultimately improving patient outcomes and reducing healthcare costs. Current reagent‐only costs now average US $65 per microbial genome, US $600 per 30× human genome, and US $130–600 per metagenomic sample when multiplexed; these figures continue to fall with higher multiplexing. To accelerate equitable adoption, we recommend near‐term payer coverage pilots for clearly defined clinical indications, dedicated CPT pathways for infectious‐disease sequencing (including metagenomic assays), and pragmatic validation frameworks that acknowledge genotype–phenotype limits while leveraging multiplexing and centralized reference workflows.
- Open Access
Lactobacillus-rich cervicovaginal microbiome associated with lower BV, HPV, and cytology outcomes in women
- Open Access
- 29 June 2025
- Published by Wiley in Microbiologyopen
- Vol. 14 (4) , e70029
Evaluation of Six Commercial and Noncommercial Colistin Resistance Diagnostics
Resistance to colistin, a last‐reserve antibiotic used for treating drug‐resistant infections, is rising globally. We compared six commercial and in‐house diagnostics—ComASP colistin, CHROMagar COL‐APSE, rapid polymyxin NP (Nordmann/Poirel) test, Sensititre, MicroScan, and Vitek 2—against ISO‐standard broth microdilution (BMD) using 142 Gram‐negative isolates. The isolates ( Enterobacterales = 110, Acinetobacter baumannii = 21, Pseudomonas aeruginosa = 11) underwent BMD and conventional multiplex PCR screening for mcr‐1 – mcr‐5 . Sensitivity, specificity, categorical agreement (CA), major error (ME), and very major error (VME) were calculated for each test. Vitek 2 and sensititre yielded the highest CA (≥ 98%) and the lowest VME (≤ 0.0%) across taxa. ComASP showed excellent performance for A. baumannii (100% sensitivity/specificity) but slightly lower CA for P. aeruginosa (73%). CHROMagar COL‐APSE demonstrated acceptable sensitivity (92%) but low specificity (69%) in Enterobacterales. MicroScan had reduced specificity in Enterobacterales (87.80%). The CHROMAgar COL‐ APSE efficiently identified the species with their unique colours but was the least specific (68.63%), with the highest ME in Enterobacterales . The rapid NP test provided rapid results within 4 h but showed a relatively high VME (7.84%), despite maintaining an acceptable sensitivity (92.16%) and specificity (96.08%). For laboratories with automated platforms, Vitek 2 remains optimal for colistin MIC testing; Sensititre and ComASP are suitable low‐cost BMD alternatives. The Rapid NP test provides a same‐day screen, but confirmatory MIC testing is advised. CHROMagar COL‐APSE should be used with a ≤ 1 CFU mL⁻¹ inoculum to minimise false resistance calls. Knowing the comparative performance of these different tests will assist in choosing the best test for every species, improving on efficient diagnosis and healthcare outcomes.
- 29 June 2025
- Published by Wiley in Microbiologyopen
- Vol. 14 (4) , e70029
Open AccessEvaluation of Six Commercial and Noncommercial Colistin Resistance Diagnostics
Resistance to colistin, a last‐reserve antibiotic used for treating drug‐resistant infections, is rising globally. We compared six commercial and in‐house diagnostics—ComASP colistin, CHROMagar COL‐APSE, rapid polymyxin NP (Nordmann/Poirel) test, Sensititre, MicroScan, and Vitek 2—against ISO‐standard broth microdilution (BMD) using 142 Gram‐negative isolates. The isolates ( Enterobacterales = 110, Acinetobacter baumannii = 21, Pseudomonas aeruginosa = 11) underwent BMD and conventional multiplex PCR screening for mcr‐1 – mcr‐5 . Sensitivity, specificity, categorical agreement (CA), major error (ME), and very major error (VME) were calculated for each test. Vitek 2 and sensititre yielded the highest CA (≥ 98%) and the lowest VME (≤ 0.0%) across taxa. ComASP showed excellent performance for A. baumannii (100% sensitivity/specificity) but slightly lower CA for P. aeruginosa (73%). CHROMagar COL‐APSE demonstrated acceptable sensitivity (92%) but low specificity (69%) in Enterobacterales. MicroScan had reduced specificity in Enterobacterales (87.80%). The CHROMAgar COL‐ APSE efficiently identified the species with their unique colours but was the least specific (68.63%), with the highest ME in Enterobacterales . The rapid NP test provided rapid results within 4 h but showed a relatively high VME (7.84%), despite maintaining an acceptable sensitivity (92.16%) and specificity (96.08%). For laboratories with automated platforms, Vitek 2 remains optimal for colistin MIC testing; Sensititre and ComASP are suitable low‐cost BMD alternatives. The Rapid NP test provides a same‐day screen, but confirmatory MIC testing is advised. CHROMagar COL‐APSE should be used with a ≤ 1 CFU mL⁻¹ inoculum to minimise false resistance calls. Knowing the comparative performance of these different tests will assist in choosing the best test for every species, improving on efficient diagnosis and healthcare outcomes.
- Open Access
- 6 June 2025
- Published by Taylor & Francis in Virulence
- Vol. 16 (1) , 2514092
Enterobacterales use capsules, transporters, mobile genetic elements, and other evolutionary adaptations to survive antibiotics exposure in the absence of resistance genes
Whole-genome sequencing, transcriptomic profiling, and epigenomic analyses were performed. Phenotypic assays were used to evaluate the effects of various inhibitors on antibiotic susceptibility, while bioinformatic pipelines were used to characterize resistance determinants, virulence factors, and mobile genetic elements (MGEs). Phylogenetic analysis revealed widespread carriage of diverse resistance genes, particularly on plasmids of K. pneumoniae, while Enterobacter species possessed fewer known ARGs. Despite lacking known carbapenemase and mcr genes, several isolates demonstrated colistin or carbapenem resistance mediated by upregulation of efflux pumps, overproduction of capsular polysaccharides, mutations in outer membrane proteins, and potential lipopolysaccharide-modifying enzymes. Transcriptomic analysis revealed significant differential gene expression upon antibiotic exposure. Notably, genes encoding ABC transporter proteins were significantly downregulated (p-value 10), while genes encoding transposases were significantly upregulated (p-value 11). These changes underscore the critical role of transporters and MGEs in antibiotic resistance adaptation. In the absence of canonical carbapenemase and mcr genes, K. pneumoniae and Enterobacter species can deploy a spectrum of adaptive mechanisms, including efflux pumps, mobile elements, and altered outer membrane/capsule structures, to overcome colistin and carbapenem treatments. These findings support the need for ongoing surveillance of novel or underrecognized resistance mechanisms to preserve the efficacy of last-line antibiotics.
- 6 June 2025
- Published by Taylor & Francis in Virulence
- Vol. 16 (1) , 2514092
Open AccessEnterobacterales use capsules, transporters, mobile genetic elements, and other evolutionary adaptations to survive antibiotics exposure in the absence of resistance genes
Whole-genome sequencing, transcriptomic profiling, and epigenomic analyses were performed. Phenotypic assays were used to evaluate the effects of various inhibitors on antibiotic susceptibility, while bioinformatic pipelines were used to characterize resistance determinants, virulence factors, and mobile genetic elements (MGEs). Phylogenetic analysis revealed widespread carriage of diverse resistance genes, particularly on plasmids of K. pneumoniae, while Enterobacter species possessed fewer known ARGs. Despite lacking known carbapenemase and mcr genes, several isolates demonstrated colistin or carbapenem resistance mediated by upregulation of efflux pumps, overproduction of capsular polysaccharides, mutations in outer membrane proteins, and potential lipopolysaccharide-modifying enzymes. Transcriptomic analysis revealed significant differential gene expression upon antibiotic exposure. Notably, genes encoding ABC transporter proteins were significantly downregulated (p-value 10), while genes encoding transposases were significantly upregulated (p-value 11). These changes underscore the critical role of transporters and MGEs in antibiotic resistance adaptation. In the absence of canonical carbapenemase and mcr genes, K. pneumoniae and Enterobacter species can deploy a spectrum of adaptive mechanisms, including efflux pumps, mobile elements, and altered outer membrane/capsule structures, to overcome colistin and carbapenem treatments. These findings support the need for ongoing surveillance of novel or underrecognized resistance mechanisms to preserve the efficacy of last-line antibiotics.
- Open Access
- 18 March 2025
- Published by American Society for Microbiology in mSystems
- Vol. 10 (3) , e0168324
Plasmid-borne mcr-1 and replicative transposition of episomal and chromosomal bla NDM-1 , bla OXA-69 , and bla OXA-23 carbapenemases in a clinical Acinetobacter baumannii isolate
A multidrug-resistant clinical Acinetobacter baumannii isolate with resistance to most antibiotics was isolated from a patient at an intensive care unit. The genetic environment, transcriptome, mobile, and resistome were characterized. The MicroScan system, disc diffusion, and broth microdilution were used to determine the resistance profile of the isolate. A multiplex PCR assay was also used to screen for carbapenemases and mcr -1 to -5 resistance genes. Efflux-pump inhibitors were used to evaluate efflux activity. The resistome, mobilome, epigenome, and transcriptome were characterized. There was phenotypic resistance to 22 of the 25 antibiotics tested, intermediate resistance to levofloxacin and nalidixic acid, and susceptibility to tigecycline, which corresponded to the 27 resistance genes found in the genome, most of which occurred in multiple copies through replicative transposition. A plasmid-borne (pR-B2.MM_C3) mcr- 1 and chromosomal bla PER-7 , bla OXA-69 , bla OXA-23 (three copies), bla ADC-25 , bla TEM-1B , and bla NDM-1 were found within composite transposons, ISs, and/or class 1 and 2 integrons on genomic islands. Types I and II methylases and restriction endonucleases were in close synteny to these resistance genes within the genomic islands; chromosomal genomic islands aligned with known plasmids. There was a closer evolutionary relationship between the strain and global strains but not local or regional strains; the resistomes also differed. Significantly expressed/repressed genes (6.2%) included resistance genes, hypothetical proteins, mobile elements, methyltransferases, transcription factors, and membrane and efflux proteins. The genomic evolution observed in this strain explains its adaptability and pandrug resistance and shows its genomic plasticity on exposure to antibiotics. IMPORTANCE: A pandrug-resistant pathogen that was susceptible to only a single antibiotic, tigecycline, was isolated from a middle-aged patient in an ICU. This pathogen contained two plasmids and had a chromosome that contained portions that were integrated externally from plasmids. These genomic islands were rich with resistance genes, mobile genetic elements, and restriction-modification systems that protected the pathogen and facilitated gene regulation. The strain contained 35 resistance genes and 12 virulence genes. The strain was of closer evolutionary distance to several international strains suggesting that it was imported into South Africa. However, its resistome was unique, suggesting an independent evolution on exposure to antibiotic therapy mediated by epigenomic factors and MGE transposition events. The varied mechanisms available to this strain to overcome antibiotic resistance and spread to other areas and/or transfer its resistance determinants are worrying. This is ultimately a risk to public health, evincing the need for antibiotic stewardship.
- 18 March 2025
- Published by American Society for Microbiology in mSystems
- Vol. 10 (3) , e0168324
Open AccessPlasmid-borne mcr-1 and replicative transposition of episomal and chromosomal bla NDM-1 , bla OXA-69 , and bla OXA-23 carbapenemases in a clinical Acinetobacter baumannii isolate
A multidrug-resistant clinical Acinetobacter baumannii isolate with resistance to most antibiotics was isolated from a patient at an intensive care unit. The genetic environment, transcriptome, mobile, and resistome were characterized. The MicroScan system, disc diffusion, and broth microdilution were used to determine the resistance profile of the isolate. A multiplex PCR assay was also used to screen for carbapenemases and mcr -1 to -5 resistance genes. Efflux-pump inhibitors were used to evaluate efflux activity. The resistome, mobilome, epigenome, and transcriptome were characterized. There was phenotypic resistance to 22 of the 25 antibiotics tested, intermediate resistance to levofloxacin and nalidixic acid, and susceptibility to tigecycline, which corresponded to the 27 resistance genes found in the genome, most of which occurred in multiple copies through replicative transposition. A plasmid-borne (pR-B2.MM_C3) mcr- 1 and chromosomal bla PER-7 , bla OXA-69 , bla OXA-23 (three copies), bla ADC-25 , bla TEM-1B , and bla NDM-1 were found within composite transposons, ISs, and/or class 1 and 2 integrons on genomic islands. Types I and II methylases and restriction endonucleases were in close synteny to these resistance genes within the genomic islands; chromosomal genomic islands aligned with known plasmids. There was a closer evolutionary relationship between the strain and global strains but not local or regional strains; the resistomes also differed. Significantly expressed/repressed genes (6.2%) included resistance genes, hypothetical proteins, mobile elements, methyltransferases, transcription factors, and membrane and efflux proteins. The genomic evolution observed in this strain explains its adaptability and pandrug resistance and shows its genomic plasticity on exposure to antibiotics. IMPORTANCE: A pandrug-resistant pathogen that was susceptible to only a single antibiotic, tigecycline, was isolated from a middle-aged patient in an ICU. This pathogen contained two plasmids and had a chromosome that contained portions that were integrated externally from plasmids. These genomic islands were rich with resistance genes, mobile genetic elements, and restriction-modification systems that protected the pathogen and facilitated gene regulation. The strain contained 35 resistance genes and 12 virulence genes. The strain was of closer evolutionary distance to several international strains suggesting that it was imported into South Africa. However, its resistome was unique, suggesting an independent evolution on exposure to antibiotic therapy mediated by epigenomic factors and MGE transposition events. The varied mechanisms available to this strain to overcome antibiotic resistance and spread to other areas and/or transfer its resistance determinants are worrying. This is ultimately a risk to public health, evincing the need for antibiotic stewardship.
- Open Access
Molecular and Pathological Characterization of Cervicovaginal Specimens Evince Significant Protection Against HPV Infections, Bacterial Vaginosis, and Epithelial Cell Abnormalities by Lactobacillus species
Background: Bacterial vaginosis (BV) results in dysbiosis in the vaginal microbiome and facilitates secondary human papilloma virus (HPV) infections, which can cause cervical abnormalities. The effects of Lactobacilli on BV-HPV infections and cervicovaginal pathology were investigated. Method. Electronic molecular and cytology laboratory results, and demographic records of 19,105 females screened for BV, HPV, and cervical cancer between August 2021 and April 2023 were collected. After data cleaning and reorganization, 15, 607 sample results were used. The data was subjected to epidemiological, statistical, and machine learning analyses to identify patterns, correlations, associations, and interactive effects of age, State, Lactobacilli, BV-associated pathogens, high-risk HPV (hrHPV) genotypes, BV, and cervical cytology. Results: The final dataset comprised of data from anonymized females (n = 15541, 99.57%), males (n = 13, 0.08%) and unknown gender (n = 53, 0.34%) between 14 and 95 years from 32 States and Washington D.C. Most samples were BV positive (n = 8282, 53.07%) and/or NILM (n = 11749) followed by 14.29% ASCUS (n = 2231), 7.14% LSIL (n = 1115), 1.04% RCC (n = 163), 0.53% HSIL (n = 82), 0.39% ASC-H (n = 61), and 0.16% AGC (n = 25). HPV-positive samples had higher BV pathogens and BV-positive diagnosis (between 51.90% and 68.60%) than BV-negative diagnosis. Lactobacillus gasseri (79.75%), Lactobacillus jensenii (82.68%), Lactobacillus crispatus (90.91%) were mostly found in BV-negative and NILM specimens. BV and ECA outcomes were significantly associated with age and State. Statistical, correlation, and machine learning models predictively confirmed these findings. Conclusion: L. crispatus, followed by L. gasseri and L. jensenii, significantly maintains a healthy cervicovaginal microbiome by inhibiting harmful bacterial pathogens and high-risk HPV subtypes; L. iners have an opposing or neutral effect.
Open AccessMolecular and Pathological Characterization of Cervicovaginal Specimens Evince Significant Protection Against HPV Infections, Bacterial Vaginosis, and Epithelial Cell Abnormalities by Lactobacillus species
Background: Bacterial vaginosis (BV) results in dysbiosis in the vaginal microbiome and facilitates secondary human papilloma virus (HPV) infections, which can cause cervical abnormalities. The effects of Lactobacilli on BV-HPV infections and cervicovaginal pathology were investigated. Method. Electronic molecular and cytology laboratory results, and demographic records of 19,105 females screened for BV, HPV, and cervical cancer between August 2021 and April 2023 were collected. After data cleaning and reorganization, 15, 607 sample results were used. The data was subjected to epidemiological, statistical, and machine learning analyses to identify patterns, correlations, associations, and interactive effects of age, State, Lactobacilli, BV-associated pathogens, high-risk HPV (hrHPV) genotypes, BV, and cervical cytology. Results: The final dataset comprised of data from anonymized females (n = 15541, 99.57%), males (n = 13, 0.08%) and unknown gender (n = 53, 0.34%) between 14 and 95 years from 32 States and Washington D.C. Most samples were BV positive (n = 8282, 53.07%) and/or NILM (n = 11749) followed by 14.29% ASCUS (n = 2231), 7.14% LSIL (n = 1115), 1.04% RCC (n = 163), 0.53% HSIL (n = 82), 0.39% ASC-H (n = 61), and 0.16% AGC (n = 25). HPV-positive samples had higher BV pathogens and BV-positive diagnosis (between 51.90% and 68.60%) than BV-negative diagnosis. Lactobacillus gasseri (79.75%), Lactobacillus jensenii (82.68%), Lactobacillus crispatus (90.91%) were mostly found in BV-negative and NILM specimens. BV and ECA outcomes were significantly associated with age and State. Statistical, correlation, and machine learning models predictively confirmed these findings. Conclusion: L. crispatus, followed by L. gasseri and L. jensenii, significantly maintains a healthy cervicovaginal microbiome by inhibiting harmful bacterial pathogens and high-risk HPV subtypes; L. iners have an opposing or neutral effect.
- Open Access
Plasmid-borne mcr-1 and Replicative Transposition of Episomal and Chromosomal blaNDM-1, blaOXA-69, and blaOXA-23 Carbapenemases in a Clinical Acinetobacter baumannii Isolate
Background: A multidrug-resistant clinical A. baumannii isolate with resistance to most antibiotics was isolated from a patient at an intensive care unit. The genetic environment, transcriptome, mobile, and resistome were characterized. Method: The MicroScan system, disc diffusion, and broth microdilution were used to determine the resistance profile of the isolate. A multiplex PCR assay was also used to screen for carbapenemases and mcr-1 to -5 resistance genes. Efflux-pump inhibitors were used to evaluate efflux activity. The resistome, mobilome, epigenome, and transcriptome were characterized. Results & conclusion: There was phenotypic resistance to 22 of the 25 antibiotics tested, intermediate resistance to levofloxacin and nalidixic acid, and susceptibility to tigecycline, which corresponded to the 27 resistance genes found in the genome, most of which occurred in multiple copies through replicative transposition. A plasmid-borne (pR-B2.MM_C3) mcr- 1 and chromosomal bla PER-7 , bla OXA-69 , bla OXA-23 (three copies), bla ADC-25 , bla TEM-1B , and bla NDM-1 were found within composite transposons, ISs, and/or class 1 and 2 integrons on genomic islands. Types I and II methylases and restriction endonucleases were in close synteny to these resistance genes within the genomic islands; chromosomal genomic islands aligned with known plasmids. There was a closer evolutionary relationship between the strain and global strains but not local or regional strains; the resistomes also differed. Significantly expressed/repressed genes (6.2%) included resistance genes, hypothetical proteins, mobile elements, methyltransferases, transcription factors, membrane and efflux proteins. The genomic evolution observed in this strain explains its adaptability and pandrug resistance and shows its genomic plasticity on exposure to antibiotics.
Open AccessPlasmid-borne mcr-1 and Replicative Transposition of Episomal and Chromosomal blaNDM-1, blaOXA-69, and blaOXA-23 Carbapenemases in a Clinical Acinetobacter baumannii Isolate
Background: A multidrug-resistant clinical A. baumannii isolate with resistance to most antibiotics was isolated from a patient at an intensive care unit. The genetic environment, transcriptome, mobile, and resistome were characterized. Method: The MicroScan system, disc diffusion, and broth microdilution were used to determine the resistance profile of the isolate. A multiplex PCR assay was also used to screen for carbapenemases and mcr-1 to -5 resistance genes. Efflux-pump inhibitors were used to evaluate efflux activity. The resistome, mobilome, epigenome, and transcriptome were characterized. Results & conclusion: There was phenotypic resistance to 22 of the 25 antibiotics tested, intermediate resistance to levofloxacin and nalidixic acid, and susceptibility to tigecycline, which corresponded to the 27 resistance genes found in the genome, most of which occurred in multiple copies through replicative transposition. A plasmid-borne (pR-B2.MM_C3) mcr- 1 and chromosomal bla PER-7 , bla OXA-69 , bla OXA-23 (three copies), bla ADC-25 , bla TEM-1B , and bla NDM-1 were found within composite transposons, ISs, and/or class 1 and 2 integrons on genomic islands. Types I and II methylases and restriction endonucleases were in close synteny to these resistance genes within the genomic islands; chromosomal genomic islands aligned with known plasmids. There was a closer evolutionary relationship between the strain and global strains but not local or regional strains; the resistomes also differed. Significantly expressed/repressed genes (6.2%) included resistance genes, hypothetical proteins, mobile elements, methyltransferases, transcription factors, membrane and efflux proteins. The genomic evolution observed in this strain explains its adaptability and pandrug resistance and shows its genomic plasticity on exposure to antibiotics.
- Open Access
- 28 June 2024
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 14, 1409774
Molecular characterization of vaginal microbiota using a new 22-species qRT-PCR test to achieve a relative-abundance and species-based diagnosis of bacterial vaginosis
Background: Numerous bacteria are involved in the etiology of bacterial vaginosis (BV). Yet, current tests only focus on a select few. We therefore designed a new test targeting 22 BV-relevant species.Methods: Using 946 stored vaginal samples, a new qPCR test that quantitatively identifies 22 bacterial species was designed. The distribution and relative abundance of each species, α- and β-diversities, correlation, and species co-existence were determined per sample. A diagnostic index was modeled from the data, trained, and tested to classify samples into BV-positive, BV-negative, or transitional BV.Results: The qPCR test identified all 22 targeted species with 95 – 100% sensitivity and specificity within 8 hours (from sample reception). Across most samples, Lactobacillus iners, Lactobacillus crispatus, Lactobacillus jensenii, Gardnerella vaginalis, Fannyhessea (Atopobium) vaginae, Prevotella bivia, and Megasphaera sp. type 1 were relatively abundant. BVAB-1 was more abundant and distributed than BVAB-2 and BVAB-3. No Mycoplasma genitalium was found. The inter-sample similarity was very low, and correlations existed between key species, which were used to model, train, and test a diagnostic index: MDL-BV index. The MDL-BV index, using both species and relative abundance markers, classified samples into three vaginal microbiome states. Testing this index on our samples, 491 were BV-positive, 318 were BV-negative, and 137 were transitional BV. Although important differences in BV status were observed between different age groups, races, and pregnancy status, they were statistically insignificant.Conclusion: Using a diverse and large number of vaginal samples from different races and age groups, including pregnant women, the new qRT-PCR test and MDL-BV index efficiently diagnosed BV within 8 hours (from sample reception), using 22 BV-associated species.
- 28 June 2024
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 14, 1409774
Open AccessMolecular characterization of vaginal microbiota using a new 22-species qRT-PCR test to achieve a relative-abundance and species-based diagnosis of bacterial vaginosis
Background: Numerous bacteria are involved in the etiology of bacterial vaginosis (BV). Yet, current tests only focus on a select few. We therefore designed a new test targeting 22 BV-relevant species.Methods: Using 946 stored vaginal samples, a new qPCR test that quantitatively identifies 22 bacterial species was designed. The distribution and relative abundance of each species, α- and β-diversities, correlation, and species co-existence were determined per sample. A diagnostic index was modeled from the data, trained, and tested to classify samples into BV-positive, BV-negative, or transitional BV.Results: The qPCR test identified all 22 targeted species with 95 – 100% sensitivity and specificity within 8 hours (from sample reception). Across most samples, Lactobacillus iners, Lactobacillus crispatus, Lactobacillus jensenii, Gardnerella vaginalis, Fannyhessea (Atopobium) vaginae, Prevotella bivia, and Megasphaera sp. type 1 were relatively abundant. BVAB-1 was more abundant and distributed than BVAB-2 and BVAB-3. No Mycoplasma genitalium was found. The inter-sample similarity was very low, and correlations existed between key species, which were used to model, train, and test a diagnostic index: MDL-BV index. The MDL-BV index, using both species and relative abundance markers, classified samples into three vaginal microbiome states. Testing this index on our samples, 491 were BV-positive, 318 were BV-negative, and 137 were transitional BV. Although important differences in BV status were observed between different age groups, races, and pregnancy status, they were statistically insignificant.Conclusion: Using a diverse and large number of vaginal samples from different races and age groups, including pregnant women, the new qRT-PCR test and MDL-BV index efficiently diagnosed BV within 8 hours (from sample reception), using 22 BV-associated species.
- Open Access
- 30 May 2024
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 14, 1429200
Editorial: Molecular mechanisms of resistance to “last resort” antimicrobials in Enterobacterales
Editorial: Molecular mechanisms of resistance to “last resort” antimicrobials in Enterobacterales
- 30 May 2024
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 14, 1429200
Open AccessEditorial: Molecular mechanisms of resistance to “last resort” antimicrobials in Enterobacterales
Editorial: Molecular mechanisms of resistance to “last resort” antimicrobials in Enterobacterales